Barden Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18M | Sell |
2,799
-163
| -6% | -$127K | 1.91% | 18 |
|
|
2025
Q1 | $2.45M | Sell |
2,962
-155
| -5% | -$128K | 2.18% | 14 |
|
|
2024
Q4 | $2.41M | Buy |
3,117
+47
| +2% | +$36.3K | 2.06% | 15 |
|
|
2024
Q3 | $2.72M | Sell |
3,070
-194
| -6% | -$172K | 2.39% | 12 |
|
|
2024
Q2 | $2.96M | Buy |
3,264
+26
| +0.8% | +$23.6K | 2.79% | 9 |
|
|
2024
Q1 | $2.52M | Sell |
3,238
-538
| -14% | -$419K | 2.43% | 11 |
|
|
2023
Q4 | $2.05M | Buy |
3,776
+548
| +17% | +$297K | 1.67% | 17 |
|
|
2023
Q3 | $1.73M | Buy |
3,228
+22
| +0.7% | +$11.8K | 1.68% | 20 |
|
|
2023
Q2 | $1.5M | Buy |
3,206
+509
| +19% | +$239K | 1.65% | 23 |
|
|
2023
Q1 | $926K | Buy |
2,697
+40
| +2% | +$13.7K | 0.89% | 46 |
|
|
2022
Q4 | $972K | Buy |
2,657
+20
| +0.8% | +$7.32K | 1% | 43 |
|
|
2022
Q3 | $853K | Buy |
+2,637
| New | +$853K | 0.99% | 45 |
|